News

Lantern Pharma Narrows Loss in Q2

Lantern Pharma reported a GAAP net loss per share of ($0.40) in Q2 2025, and marking an improvement from ($0.46) per share (GAAP) in Q2 2024. As expected for a clinical-stage biotech, no product ...

Nasdaq CEO on being honored by the New York Fire Department

Adena Friedman, Nasdaq Chair & CEO, joins 'Fast Money' to discuss the boom in the IPO market, the dealmaking environment and ...

Spectral Ai Posts 32% Revenue Drop in Q2

Key Points Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year ...

Dow Jones Top Company Headlines at 7 PM ET: Cisco Posts Higher Earnings, Revenue on AI Infrastructure Demand | Tesla ...

Dow Jones Top Company Headlines at 7 PM ET: Cisco Posts Higher Earnings, Revenue on AI Infrastructure Demand | Tesla ... The tech company reported earnings that beat estimates after AI infrastructure ...

Cisco Q4 Revenue Jumps on AI Demand

Cisco(NASDAQ:CSCO) reported fourth quarter fiscal 2025 results on Aug. 13, 2025, posting total revenue of $14.7 billion (up 8% YoY) and non-GAAP EPS of $0.99 (up 14% YoY), with product orders rising 7 ...